Singular Genomics Systems, Inc. Common Stock
OMIC
OMIC was delisted on the 20th of February, 2025.
47 hedge funds and large institutions have $12.1M invested in Singular Genomics Systems, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 6 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
14% more capital invested
Capital invested by funds: $10.6M → $12.1M (+$1.53M)
1.23% less ownership
Funds ownership: 36.93% → 35.7% (-1.2%)
2% less funds holding
Funds holding: 48 → 47 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
43% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QM
QVIDTVM Management
The Woodlands,
Texas
|
+$446K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$156K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$59.1K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$22.2K |
| 5 |
WC
Weil Company
San Diego,
California
|
+$7.89K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$234K |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
-$199K |
| 3 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$163K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$137K |
| 5 |
PA
Perceptive Advisors
New York
|
-$93.2K |
OMIC Hedge Fund Activity: Q4 2023 in Review
47 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q4 2023, worth a combined $12.1M — up 14% from $10.6M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of OMIC and 5 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 8 added.
The largest buyer was QVIDTVM Management, adding an estimated $446K. The largest seller was Millennium Management, cutting an estimated $234K.
- 47 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q4 2023, down from 48 in Q3 2023.
- Funds reported $12.1M of Singular Genomics Systems, Inc. Common Stock stock for Q4 2023, up 14% quarter-over-quarter.
- 5 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q4 2023 and 6 closed out, a net change of -1 holder.
- The largest Singular Genomics Systems, Inc. Common Stock buyer in Q4 2023 was QVIDTVM Management, an estimated $446K added.
- The largest Singular Genomics Systems, Inc. Common Stock seller in Q4 2023 was Millennium Management, an estimated $234K sold.
Based on aggregated 13F filings for Q4 2023.